Expression profile of pancreatic cancer
    3.
    发明申请
    Expression profile of pancreatic cancer 审中-公开
    胰腺癌的表达谱

    公开(公告)号:US20050009067A1

    公开(公告)日:2005-01-13

    申请号:US10848259

    申请日:2004-05-18

    摘要: The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides gene expression profiles associated with pancreatic cancers. Genes identified as cancer markers using the methods of the present invention find use in the diagnosis and characterization of pancreatic cancer. In addition, the genes provide targets for cancer drug screens and therapeutic applications.

    摘要翻译: 本发明涉及用于癌症诊断的组合物和方法,包括但不限于癌症标志物。 特别地,本发明提供了与胰腺癌相关的基因表达谱。 使用本发明的方法鉴定为癌症标志物的基因可用于胰腺癌的诊断和表征。 此外,这些基因为癌症药物筛选和治疗应用提供了靶标。

    Methods for Diagnosing The Malignant Potential of Pancreatic Cystic Lesions
    8.
    发明申请
    Methods for Diagnosing The Malignant Potential of Pancreatic Cystic Lesions 审中-公开
    诊断胰腺囊性病变恶性潜力的方法

    公开(公告)号:US20130005598A1

    公开(公告)日:2013-01-03

    申请号:US13519766

    申请日:2010-12-30

    摘要: A method of diagnosing the malignant potential of a pancreatic cystic lesion in a subject including: detecting a glycan alteration in MUC5AC in a sample of pancreatic cystic lesion fluid from a subject, determining whether the glycan alteration is differentially present in the sample, and diagnosing the malignant potential of the pancreatic cystic lesion. A method of diagnosing the malignant potential of a pancreatic cystic lesion in a subject including: (a) detecting a glycan alteration in MUC5AC in a sample of pancreatic cystic lesion fluid from a subject, (b) detecting CA 19-9 in the sample, (c) determining whether the glycan alteration and CA 19-9 are differentially present in the sample, and (d) diagnosing the malignant potential of the pancreatic cystic lesion. Related methods of treatment and kits also are included.

    摘要翻译: 一种诊断受试者胰腺囊性病变的恶性潜力的方法,包括:检测来自受试者的胰腺囊性病变液样品中MUC5AC的聚糖改变,确定样品中是否差异存在聚糖改变,并诊断 胰腺囊性病变的恶性潜能。 一种诊断受试者胰腺囊性病变恶性潜力的方法,包括:(a)检测来自受试者的胰腺囊性病变液样品中MUC5AC的聚糖改变,(b)检测样品中的CA 19-9, (c)确定样品中聚糖改变和CA19-9是否差异存在,以及(d)诊断胰腺囊性病变的恶性潜能。 还包括相关治疗方法和试剂盒。